Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.78 USD | -0.84% | -4.55% | -9.15% |
May. 02 | North American Morning Briefing : Stock Futures -3- | DJ |
Apr. 30 | Needham Lowers Price Target on NeoGenomics to $19 From $24 Due to Peer Multiple Compression, Maintains Buy Rating | MT |
Business Summary
Number of employees: 2,100
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Clinical Services
83.8
%
| 419 | 82.2 % | 496 | 83.8 % | +18.36% |
Advanced Diagnostics
16.2
%
| 91 | 17.8 % | 96 | 16.2 % | +5.53% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 510 | 100.0 % | 592 | 100.0 % | +16.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chris Smith
CEO | Chief Executive Officer | 61 | 22-08-14 |
Lynn Tetrault
CHM | Chairman | 61 | 15-06-11 |
Jeffrey Sherman
DFI | Director of Finance/CFO | 58 | 22-12-06 |
Derek Lyle
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Chief Tech/Sci/R&D Officer | 57 | 22-03-06 | |
Greg Sparks
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Hutan Hashemi
CMP | Compliance Officer | 45 | 22-02-28 |
Chief Tech/Sci/R&D Officer | - | - | |
Melody Harris
COO | Chief Operating Officer | 58 | 22-12-04 |
Steven Ross
CTO | Chief Tech/Sci/R&D Officer | 60 | 13-04-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Crowther
BRD | Director/Board Member | 72 | 14-10-21 |
Michael Kelly
BRD | Director/Board Member | 67 | 20-07-14 |
Chris Smith
CEO | Chief Executive Officer | 61 | 22-08-14 |
David Perez
BRD | Director/Board Member | 63 | 22-11-02 |
Anthony Zook
BRD | Director/Board Member | 63 | 23-06-25 |
Lynn Tetrault
CHM | Chairman | 61 | 15-06-11 |
Stephen Kanovsky
BRD | Director/Board Member | 61 | 17-07-18 |
Alison Hannah
BRD | Director/Board Member | 63 | 15-06-11 |
Neil Gunn
BRD | Director/Board Member | 63 | 23-06-25 |
Director/Board Member | 48 | 23-06-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 127,711,930 | 126,076,930 ( 98.72 %) | 0 | 98.72 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.85% | 1.9B | |
-22.04% | 8.54B | |
+68.22% | 4.32B | |
-1.43% | 2.53B | |
-9.63% | 2.46B | |
-38.23% | 2.48B | |
-17.74% | 1.59B | |
-39.48% | 1.23B | |
+9.68% | 1.13B | |
+16.07% | 994M |
- Stock Market
- Equities
- NEO Stock
- Company NeoGenomics, Inc.